LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 333

Search options

  1. Article ; Online: Genome-wide association study of lipase and esterase in wholegrain wheat flour (Triticum aestivum L.).

    Wei, Chun Yue / Yates, Steven / Zhu, Dan / Hund, Andreas / Studer, Bruno / Nyström, Laura

    PloS one

    2023  Volume 18, Issue 3, Page(s) e0282510

    Abstract: Lipase activity is one of the main causes of the lipid rancidity in wholegrain wheat flour, leading to its short shelf life. Genetically diverse wheat germplasm offers potential for the selection of wheat cultivars with low lipase activity for stable ... ...

    Abstract Lipase activity is one of the main causes of the lipid rancidity in wholegrain wheat flour, leading to its short shelf life. Genetically diverse wheat germplasm offers potential for the selection of wheat cultivars with low lipase activity for stable wholegrain end use. This study evaluated 300 European wheat cultivars harvested in 2015 and 2016 on the genetic association of lipase and esterase activities in wholegrain wheat flour. Esterase and lipase activities in wholegrain flour were measured photometrically with p-nitrophenyl butyrate and p-nitrophenyl palmitate as substrates, respectively. Both enzyme activities showed wide ranges among all cultivars within each year, with differences up to 2.5-fold. The two years showed low correlations between each other, indicating a large environmental impact on the enzyme activities. Cultivars 'Julius' and 'Bueno' were suggested to be better suited for stable wholegrain products, as they had consistently low esterase and lipase activities compared to the other cultivars. A genome-wide association study revealed associations with single nucleotide polymorphisms in genes located on the high-quality wheat genome sequence of the International Wheat Genome Sequencing Consortium. Eight and four candidate genes were tentatively proposed to be associated to esterase and lipase activity, respectively, in wholegrain flour. Our work shows esterase and lipase activities from a new perspective, that combines reverse genetics to understand the underlying causes. This study outlines the possibilities and limitations to improve lipid stability of wholegrain wheat by genomics-assisted breeding methods, thereby offering new opportunities to optimize the quality of wholegrain wheat flour and wholegrain products.
    MeSH term(s) Lipase/genetics ; Esterases/genetics ; Flour ; Genome-Wide Association Study ; Triticum/genetics ; Plant Breeding ; Lipids
    Chemical Substances Lipase (EC 3.1.1.3) ; Esterases (EC 3.1.-) ; Lipids
    Language English
    Publishing date 2023-03-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0282510
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Battling contagious diseases

    Yates, Laura

    Dental Nursing

    Abstract: Laura Yates looks at precautions to take to prevent the spread of infection within the dental ...

    Abstract Laura Yates looks at precautions to take to prevent the spread of infection within the dental practice
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #833218
    Database COVID19

    Kategorien

  3. Article ; Online: Immunoregulation of asthma by type 2 cytokine therapies: Treatments for all ages?

    Saglani, Sejal / Yates, Laura / Lloyd, Clare M

    European journal of immunology

    2023  Volume 53, Issue 8, Page(s) e2249919

    Abstract: Asthma is classically considered to be a disease of type 2 immune dysfunction, since many patients exhibit the consequences of excess secretion of cytokines such as IL-4, IL-5, and IL-13 concomitant with inflammation typified by eosinophils. Mouse and ... ...

    Abstract Asthma is classically considered to be a disease of type 2 immune dysfunction, since many patients exhibit the consequences of excess secretion of cytokines such as IL-4, IL-5, and IL-13 concomitant with inflammation typified by eosinophils. Mouse and human disease models have determined that many of the canonical pathophysiologic features of asthma may be caused by these disordered type 2 immune pathways. As such considerable efforts have been made to develop specific drugs targeting key cytokines. There are currently available multiple biologic agents that successfully reduce the functions of IL-4, IL-5, and IL-13 in patients, and many improve the course of severe asthma. However, none are curative and do not always minimize the key features of disease, such as airway hyperresponsiveness. Here, we review the current therapeutic landscape targeting type 2 immune cytokines and discuss evidence of efficacy and limitations of their use in adults and children with asthma.
    MeSH term(s) Adult ; Child ; Humans ; Animals ; Mice ; Interleukin-13 ; Interleukin-5 ; Interleukin-4 ; Asthma ; Eosinophils ; Cytokines
    Chemical Substances Interleukin-13 ; Interleukin-5 ; Interleukin-4 (207137-56-2) ; Cytokines
    Language English
    Publishing date 2023-04-03
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.202249919
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes: an economic evaluation of the 48-month PROPELS randomized controlled trial.

    Heathcote, Laura Ellen / Pollard, Daniel J / Brennan, Alan / Davies, Melanie J / Eborall, Helen / Edwardson, Charlotte L / Gillett, Michael / Gray, Laura J / Griffin, Simon J / Hardeman, Wendy / Henson, Joseph / Khunti, Kamlesh / Sharp, Stephen / Sutton, Stephen / Yates, Thomas

    BMJ open diabetes research & care

    2024  Volume 12, Issue 2

    Abstract: Introduction: Physical activity (PA) is protective against type 2 diabetes (T2D). However, data on pragmatic long-term interventions to reduce the risk of developing T2D via increased PA are lacking. This study investigated the cost-effectiveness of a ... ...

    Abstract Introduction: Physical activity (PA) is protective against type 2 diabetes (T2D). However, data on pragmatic long-term interventions to reduce the risk of developing T2D via increased PA are lacking. This study investigated the cost-effectiveness of a pragmatic PA intervention in a multiethnic population at high risk of T2D.
    Materials and methods: We adapted the School for Public Health Research diabetes prevention model, using the PROPELS trial data and analyses of the NAVIGATOR trial. Lifetime costs, lifetime quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) were calculated for each intervention (Walking Away (WA) and Walking Away Plus (WA+)) versus usual care and compared with National Institute for Health and Care Excellence's willingness-to-pay of £20 000-£30 000 per QALY gained. We conducted scenario analyses on the outcomes of the PROPELS trial data and a threshold analysis to determine the change in step count that would be needed for the interventions to be cost-effective.
    Results: Estimated lifetime costs for usual care, WA, and WA+ were £22 598, £23 018, and £22 945, respectively. Estimated QALYs were 9.323, 9.312, and 9.330, respectively. WA+ was estimated to be more effective and cheaper than WA. WA+ had an ICER of £49 273 per QALY gained versus usual care. In none of our scenario analyses did either WA or WA+ have an ICER below £20 000 per QALY gained. Our threshold analysis suggested that a PA intervention costing the same as WA+ would have an ICER below £20 000/QALY if it were to achieve an increase in step count of 500 steps per day which was 100% maintained at 4 years.
    Conclusions: We found that neither WA nor WA+ was cost-effective at a limit of £20 000 per QALY gained. Our threshold analysis showed that interventions to increase step count can be cost-effective at this limit if they achieve greater long-term maintenance of effect.
    Trial registration number: ISRCTN registration: ISRCTN83465245: The PRomotion Of Physical activity through structuredEducation with differing Levels of ongoing Support for those with pre-diabetes (PROPELS)https://doi.org/10.1186/ISRCTN83465245.
    MeSH term(s) Humans ; Cost-Benefit Analysis ; Cost-Effectiveness Analysis ; Diabetes Mellitus, Type 2 ; Exercise ; Walking
    Language English
    Publishing date 2024-03-12
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 2732918-5
    ISSN 2052-4897 ; 2052-4897
    ISSN (online) 2052-4897
    ISSN 2052-4897
    DOI 10.1136/bmjdrc-2023-003516
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Understanding the Experiences of Living With an Artificial Eye in Children With Retinoblastoma-Perspectives of Children and Their Parents.

    Gibbs, Deanna / Reynolds, Laura / Shea Yates, Tara

    Journal of pediatric hematology/oncology nursing

    2022  Volume 39, Issue 4, Page(s) 250–263

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Child ; Eye, Artificial ; Humans ; Parenting ; Parents ; Qualitative Research ; Retinal Neoplasms/surgery ; Retinoblastoma/surgery
    Language English
    Publishing date 2022-03-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2752-7549
    ISSN (online) 2752-7549
    DOI 10.1177/27527530211073688
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Mast cell activation disrupts interactions between endothelial cells and pericytes during early life allergic asthma.

    Joulia, Régis / Puttur, Franz / Stölting, Helen / Traves, William J / Entwistle, Lewis J / Voitovich, Anastasia / Garcia Martín, Minerva / Al-Sahaf, May / Bonner, Katie / Scotney, Elizabeth / Molyneaux, Philip L / Hewitt, Richard J / Walker, Simone A / Yates, Laura / Saglani, Sejal / Lloyd, Clare M

    The Journal of clinical investigation

    2024  Volume 134, Issue 6

    Abstract: Allergic asthma generally starts during early life and is linked to substantial tissue remodeling and lung dysfunction. Although angiogenesis is a feature of the disrupted airway, the impact of allergic asthma on the pulmonary microcirculation during ... ...

    Abstract Allergic asthma generally starts during early life and is linked to substantial tissue remodeling and lung dysfunction. Although angiogenesis is a feature of the disrupted airway, the impact of allergic asthma on the pulmonary microcirculation during early life is unknown. Here, using quantitative imaging in precision-cut lung slices (PCLSs), we report that exposure of neonatal mice to house dust mite (HDM) extract disrupts endothelial cell/pericyte interactions in adventitial areas. Central to the blood vessel structure, the loss of pericyte coverage was driven by mast cell (MC) proteases, such as tryptase, that can induce pericyte retraction and loss of the critical adhesion molecule N-cadherin. Furthermore, spatial transcriptomics of pediatric asthmatic endobronchial biopsies suggests intense vascular stress and remodeling linked with increased expression of MC activation pathways in regions enriched in blood vessels. These data provide previously unappreciated insights into the pathophysiology of allergic asthma with potential long-term vascular defects.
    MeSH term(s) Humans ; Child ; Animals ; Mice ; Mast Cells/pathology ; Pericytes/metabolism ; Endothelial Cells/metabolism ; Asthma/pathology ; Lung/pathology ; Allergens ; Pyroglyphidae ; Disease Models, Animal
    Chemical Substances Allergens
    Language English
    Publishing date 2024-03-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI173676
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial.

    Gardener, Samantha L / Fuller, Stephanie J / Naismith, Sharon L / Baker, Laura / Kivipelto, Miia / Villemagne, Victor L / Grieve, Stuart M / Yates, Paul / Rainey-Smith, Stephanie R / Chen, Juliana / Thompson, Belinda / Armstrong, Nicola J / Fernando, Malika G / Blagojevic Castro, Carolina / Meghwar, Silochna / Raman, Rema / Gleason, Andrew / Ireland, Catriona / Clarnette, Roger /
    Anstey, Kaarin J / Taddei, Kevin / Garg, Manohar / Sohrabi, Hamid R / Martins, Ralph N

    Alzheimer's & dementia (New York, N. Y.)

    2024  Volume 10, Issue 2, Page(s) e12466

    Abstract: Introduction: The Finnish Geriatric Intervention Study (FINGER) led to the global dementia risk reduction initiative: World-Wide FINGERS (WW-FINGERS). As part of WW-FINGERS, the Australian AU-ARROW study mirrors aspects of FINGER, as well as US-POINTER.! ...

    Abstract Introduction: The Finnish Geriatric Intervention Study (FINGER) led to the global dementia risk reduction initiative: World-Wide FINGERS (WW-FINGERS). As part of WW-FINGERS, the Australian AU-ARROW study mirrors aspects of FINGER, as well as US-POINTER.
    Method: AU-ARROW is a randomized, single-blind, multisite, 2-year clinical trial (
    Discussion: The finalized AU-ARROW protocol is expected to allow development of an evidence-based innovative treatment plan to reduce cognitive decline and dementia risk, and effective transfer of research outcomes into Australian health policy.
    Highlights: Study protocol for a single-blind, randomized controlled trial, the AU-ARROW Study.The AU-ARROW Study is a member of the World-Wide FINGERS (WW-FINGERS) initiative.AU-ARROW's primary outcome measure is change in a global composite cognitive score.Extra significance from amyloid PET imaging, brain MRI, and retinal biomarker tests.Leading to development of an innovative treatment plan to reduce cognitive decline.
    Language English
    Publishing date 2024-04-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2832891-7
    ISSN 2352-8737 ; 2352-8737
    ISSN (online) 2352-8737
    ISSN 2352-8737
    DOI 10.1002/trc2.12466
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Going for gold: Sports and exercise groups for people with dementia and carers contribute to their well-being.

    Chadwick, Claire / Hussain, Aisha / Carone, Laura / Yates, Jen / Dening, Tom

    Frontiers in rehabilitation sciences

    2022  Volume 3, Page(s) 953822

    Abstract: Background: Interventions involving exercise appear to have positive effects, both for people with dementia and for their carers. Quality of life and well-being are especially important outcomes. This study investigated how a sports and exercise group ... ...

    Abstract Background: Interventions involving exercise appear to have positive effects, both for people with dementia and for their carers. Quality of life and well-being are especially important outcomes. This study investigated how a sports and exercise group for people with dementia and their carers could contribute to the well-being of those attending the group.
    Methods: The study was a qualitative investigation, comprising semi-structured interviews, a focus group and observations. Participants included people with dementia and carers attending the group sessions, as well as staff providing the programme. The group sessions were provided weekly by the charitable trust of a leading sports venue. Data were analysed using thematic analysis.
    Results: A total of 16 participants were interviewed, including four people with dementia, eight carers, and four members of staff. Five main themes were identified: "Support to keep active and engaged is highly valued by people with dementia and carers"; "The challenges of being a carer are significant but sharing the experience really helps"; "People with dementia can have flourishing social lives"; "The group helps to maintain identity despite physical and role changes"; and "There are practical aspects of the group that make it appealing".
    Discussion: People with dementia enjoy physical activity and experience the benefits of it. The sports and exercise group had an important role in providing access to activities that people with dementia and their carers value and enjoy, but would be difficult to undertake without a facilitated and safe environment. The group benefited the well-being of both people with dementia and carers in various ways, with peer support being of particular importance for carers.
    Language English
    Publishing date 2022-09-01
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2673-6861
    ISSN (online) 2673-6861
    DOI 10.3389/fresc.2022.953822
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Lung extracellular matrix modulates KRT5

    Hewitt, Richard J / Puttur, Franz / Gaboriau, David C A / Fercoq, Frédéric / Fresquet, Maryline / Traves, William J / Yates, Laura L / Walker, Simone A / Molyneaux, Philip L / Kemp, Samuel V / Nicholson, Andrew G / Rice, Alexandra / Roberts, Edward / Lennon, Rachel / Carlin, Leo M / Byrne, Adam J / Maher, Toby M / Lloyd, Clare M

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 6039

    Abstract: Aberrant expansion of ... ...

    Abstract Aberrant expansion of KRT5
    MeSH term(s) Humans ; Idiopathic Pulmonary Fibrosis ; Extracellular Matrix ; Alveolar Epithelial Cells ; Biological Transport ; Cell Movement ; Keratin-5
    Chemical Substances KRT5 protein, human ; Keratin-5
    Language English
    Publishing date 2023-09-27
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-41621-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).

    Parkman, Henry P / Yates, Katherine P / Sarosiek, Irene / Bulat, Robert S / Abell, Thomas L / Koch, Kenneth L / Kuo, Braden / Grover, Madhusudan / Farrugia, Gianrico / Silver, Paul / Abdullah, Amirah / Maurer, Alan H / Malik, Zubair / Miriel, Laura A / Tonascia, James / Hamilton, Frank / Pasricha, Pankaj J / McCallum, Richard W

    Alimentary pharmacology & therapeutics

    2023  Volume 57, Issue 11, Page(s) 1272–1289

    Abstract: Background: Patients with gastroparesis and related disorders have symptoms including early satiety, postprandial fullness and bloating. Buspirone, a 5-HT: Aim: To determine if buspirone treatment improves early satiety and postprandial fullness in ... ...

    Abstract Background: Patients with gastroparesis and related disorders have symptoms including early satiety, postprandial fullness and bloating. Buspirone, a 5-HT
    Aim: To determine if buspirone treatment improves early satiety and postprandial fullness in patients with symptoms of gastroparesis.
    Methods: This 4-week multi-centre clinical trial randomised patients with symptoms of gastroparesis and moderate-to-severe symptoms of fullness (Gastroparesis Cardinal Symptom Index [GCSI] early satiety/postprandial fullness subscore [ES/PPF]) to buspirone (10 mg orally) or placebo three times per day. The primary outcome was a change in the ES/PPF from baseline to 4 weeks. The primary analysis was per protocol intention-to-treat ANCOVA of between-group baseline vs. 4-week differences (DoD) in ES/PPF adjusted for baseline ES/PPF. Results are reported using both nominal and Bonferroni (BF) p values.
    Results and conclusions: Ninety-six patients (47 buspirone, 49 placeboes; 92% female, 50% delayed gastric emptying, 39% diabetic) were enrolled. There was no between-groups difference in the 4-week ES/PPF primary outcome: -1.16 ± 1.25 (SD) on buspirone vs -1.03 ± 1.29 (SD) on placebo (mean DoD: -0.11 [95% CI: -0.68, 0.45]; p = 0.69). Buspirone performed better than placebo in patients with severe-to-very severe bloating at baseline compared to patients with none to moderate: (ES/PPF DoD = -0.65 vs. 1.58, p
    Conclusions: Patients with moderate-to-severe early satiety/postprandial fullness and other symptoms of gastroparesis did not benefit from buspirone treatment to improve the ES/PPF primary outcome compared with placebo. There was a suggestion of the benefit of buspirone in patients with more severe bloating.
    Trial registration: ClinicalTrials.gov NCT0358714285.
    MeSH term(s) Humans ; Female ; Male ; Buspirone/therapeutic use ; Gastroparesis/drug therapy ; Gastroparesis/diagnosis ; Double-Blind Method ; Gastric Emptying
    Chemical Substances Buspirone (TK65WKS8HL)
    Language English
    Publishing date 2023-04-13
    Publishing country England
    Document type Randomized Controlled Trial ; Multicenter Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17479
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top